1Colacurci N,De Franciscis P,Cobellis L,et al.Effects of hormone replacement therapy on postmenopausal uterine myoma.Maturitas,2000,35(2):167-173
2Palomba S,Sena T,Morelli M,et al.Effect of different doses of progestin on uterine leiomyomas in postmenopausal women.Eur J Obstet Gynecol Reprod Biol,2002,102(2):199-201
3Matorras R,Elorriaga MA,Pijoan JI,et al.Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy.Fertil Steril,2002,77(2):303-308
4Lundstrom E,Wilczek B,von Pallfy Z,et al.Mammographic breast density during hormone replacement therapy:effects of continuous combination,unopposed transdermal and low-potency estrogen regimens.Climacteric,2001,4(1):42-48
5Yenen MC,Dede M,Goktolga U,et al.Hormone replacement therapy in postmenopausal women with benign fibrocystic mastopathy.Climacteric,2003,6(2):146-150
6Ferrara A,Karter AJ,Ackerson LM,et al.Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes:the Northern California Kaiser Permanente Diabetes Registry.Diabetes Care,2001,24(7):1144-1150
7Rossouw JE,Anderson GL,Prentice RL,et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the Women's Health Initiative randomized controlled trial.JAMA,2002,288(3):321-333
8Baber RJ,O'Hara JL,Boyle FM,et al.Hormone replacement therapy:to use or not to use? Med J Aust,2003,178(12):630-633
9Van Gorp T,Neven P.Endometrial safety of hormone replacement therapy:review of literature.Maturitas,2002,42(2):93-104
10Mosca L,Collins P,Herrington DM,et al.Hormone replacement therapy and cardiovascular disease:a statement for healthcare professionals from the American Heart Association.Circulation,2001,104(4):499-503
